Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05672901 · ClinicalTrials.gov registry record · NA

Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause

A NA study of Genitourinary Syndrome of Menopause, sponsored by Stratpharma.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT05672901 is a NA study of Genitourinary Syndrome of Menopause that is actively recruiting participants, run by Stratpharma. The registered enrollment target is 100 participants, below the 370-participant average among 6 other Genitourinary Syndrome of Menopause trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05672901, a NA study of Genitourinary Syndrome of Menopause, is actively recruiting participants, sponsored by Stratpharma.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

The goal of this randomized controlled trial is to test the efficacy of StrataMGT in the management of Genitourinary Syndrome of Menopause (GSM) compared to estrogen therapy. The main question it aims to answer is: \- Will StrataMGT be non-inferior regarding patient quality of life compared to standard of care? Participants will use either StrataMGT or estrogen vaginal cream to treat GSM for 3 consecutive months. After the baseline assessment, participants will be assessed monthly for quality of life, clinical signs, symptoms, pathology and adverse reactions.

Conditions Studied

Genitourinary Syndrome of Menopause

Interventions

  • DEVICE StrataMGT
  • DRUG Estrace 0.01% Vaginal Cream

Study Locations (3)

California

  • Orange Coast Women's Medical Group - Laguna Hills

Florida

  • Abba Medical Group - Miami

Georgia

  • One Health Research Clinic - Johns Creek

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-04-04
Est. Completion 2026-09
Phase NA

Sponsor

Stratpharma

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05672901

The ClinicalTrials.gov registry entry for NCT05672901 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 370-participant average among 6 other Genitourinary Syndrome of Menopause trials with a reported enrollment target (73% lower). The listed sponsor is Stratpharma, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Genitourinary Syndrome of Menopause appearing as the primary indexed condition, and to 2 interventions - of which StrataMGT is the first listed.

NCT05672901 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT05672901 about?

NCT05672901 is a clinical study titled "Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause". The goal of this randomized controlled trial is to test the efficacy of StrataMGT in the management of Genitourinary Syndrome of Menopause (GSM) compared to estrogen therapy. The main question it aims to answer is: \- Will StrataMGT be non-inferior regarding patient quality of life compared to stan...

What is the current status of trial NCT05672901?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-04. Estimated completion is 2026-09.

What conditions does trial NCT05672901 study?

This clinical trial studies the following conditions: Genitourinary Syndrome of Menopause.

What interventions are being tested in trial NCT05672901?

The interventions under investigation include: StrataMGT (DEVICE), Estrace 0.01% Vaginal Cream (DRUG).

Who is sponsoring clinical trial NCT05672901?

This trial is sponsored by Stratpharma, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05672901 being conducted?

This trial has 3 study locations across California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Genitourinary Syndrome of Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Genitourinary Syndrome of Menopause

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.